Article
Overexpression of PFKFB3 promotes cell glycolysis and proliferation in renal cell carcinoma
20 Jan 2022
Abstract excerpt
BACKGROUND: Cancer cells prefer utilizing aerobic glycolysis in order to exacerbate tumor mass and maintain un-regulated proliferative rates. As a key glycolytic activator, phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3) has been implicated in multiple tumor type progression. However, the specific function and clinical significance of PFKFB3 in renal cell carcinoma (RCC) are yet not clarified. This...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
